Reduced Pulmonary Artery Distensibility Predicts Persistent Pulmonary Hypertension and 2-Year Mortality in Patients with Severe Aortic Stenosis Undergoing TAVR

Copyright © 2023 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved..

RATIONALE AND OBJECTIVES: Post-TAVR persistent pulmonary hypertension (PH) is a better predictor of poor outcome than pre-TAVR PH. In this longitudinal study we sought to evaluate whether pulmonary artery (distensibility (DPA) measured on preprocedural ECG-gated CTA is associated with persistent-PH and 2-year mortality after TAVR.

MATERIALS AND METHODS: Three hundred and thirty-six patients undergoing TAVR between July 2012 and March 2016 were retrospectively included and followed for all-cause mortality until November 2017. All patients underwent retrospectively ECG-gated CTA prior to TAVR. Main pulmonary artery (MPA) area was measured in systole and in diastole. DPA was calculated as: [(area-MPAmax-area-MPAmin)/area-MPAmax]%. ROC analysis was performed to assess the AUC for persistent-PH. Youden Index was used to determine the optimal threshold of DPA for persistent-PH. Two groups were compared based on a DPA threshold of 8% (specificity of 70% for persistent-PH). Kaplan-Meier, Cox proportional-hazard, and logistic regression analyses were performed. The primary clinical endpoint was defined as persistent-PH post-TAVR. The secondary endpoint was defined as all-cause mortality 2 years after TAVR.

RESULTS: Median follow-up time was 413 (interquartiles 339-757) days. A total of 183 (54%) had persistent-PH and 68 (20%) patients died within 2-years after TAVR. Patients with DPA<8% had significantly more persistent-PH (67% vs 47%, p<0.001) and 2-year deaths (28% vs 15%, p=0.006), compared to patients with DPA>8%. Adjusted multivariable regression analyses showed that DPA<8% was independently associated with persistent-PH (OR 2.10 [95%-CI 1.3-4.5], p=0.007) and 2-year mortality (HR 2.91 [95%-CI 1.5-5.8], p=0.002). Kaplan-Meier analysis showed that 2-year mortality of patients with DPA<8% was significantly higher compared to patients with DPA≥8% (mortality 28% vs 15%; log-rank p=0.003).

CONCLUSION: DPA on preprocedural CTA is independently associated with persistent-PH and two-year mortality in patients who undergo TAVR.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:30

Enthalten in:

Academic radiology - 30(2023), 12 vom: 16. Dez., Seite 2825-2833

Sprache:

Englisch

Beteiligte Personen:

Turner, Valery [VerfasserIn]
Maret, Eva [VerfasserIn]
Kim, Juyong B [VerfasserIn]
Codari, Marina [VerfasserIn]
Hinostroza, Virginia [VerfasserIn]
Mastrodicasa, Domenico [VerfasserIn]
Watkins, A Claire [VerfasserIn]
Fearon, William F [VerfasserIn]
Fischbein, Michael P [VerfasserIn]
Haddad, Francois [VerfasserIn]
Willemink, Martin J [VerfasserIn]
Fleischmann, Dominik [VerfasserIn]

Links:

Volltext

Themen:

Computed tomography angiography
Journal Article
Pulmonary artery
Pulmonary hypertension
Transcatheter aortic valve replacement

Anmerkungen:

Date Completed 01.12.2023

Date Revised 10.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.acra.2023.03.014

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM356503321